Showing results (11-20 of 13) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Lancet. Gastroenterology & Hepatology|April 3, 2018
Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trialAnne S Strik, Wim van de Vrie, Joanne P J Bloemsaat-Minekus, et al.Scandinavian Journal of Gastroenterology|December 8, 2020
Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trialAnne S Strik, Mark Löwenberg, Diane R Mould, et al.Scientific Reports|August 31, 2019
Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanismsSara Botschuijver, Sophie A van Diest, Isabelle A M van Thiel, et al.Pageof 2